A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Clinical trial NCT04978727 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04978727
Sponsor: Children's Oncology Group
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Medulloblastoma Glioblastoma Multiforme Anaplastic Astrocytoma High-grade Astrocytoma NOS Anaplastic Oligodendroglioma Anaplastic Ependymoma Ependymoma Diffuse Intrinsic Pontine Glioma

Start date: 2022-07-01
Primary completion: 2027-12-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.